Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-30 @ 9:00 AM
Study NCT ID:
NCT01946204
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-19
First Post:
2013-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Aragon Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2013-09-17
First Submit QC Date:
None
Study First Post Date:
2013-09-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-18
Results First Submit QC Date:
None
Results First Post Date:
2018-06-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED